Gene Arey

FDA investigator

Appears on 6 documents from 2015 to 2022, most often at sites in North Carolina. Most often cites production record review (21 CFR 211.192).

6
Documents on file
4.8
Observations per 483
2015
First seen
2022
Most recent

What they cite most

From 23 observations

Activity by year

2015: 1, 2016: 2, 2018: 1, 2019: 1, 2022: 1

Where

North Carolina 2 · Spain 1 · Switzerland 1 · United Kingdom 1

Is Gene Arey coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 Form 483 · FEI 3011292311Sep 23, 2022
483 Instituto Grifols, S.A.Jun 25, 2019 · Parets Del Valles, Spain
483 Valneva Scotland Ltd.Apr 24, 2018 · Livingston, United Kingdom
483 Grifols Therapeutics LLCOct 21, 2016 · Clayton, North Carolina
483 Seqirus IncMay 17, 2016 · Holly Springs, North Carolina
483 Bavarian Nordic Berna GmbHSep 11, 2015 · Thörishaus, Switzerland

About this profile

What does Gene Arey inspect?

Gene Arey appears on 6 documents on file covering 6 sites, most often in North Carolina.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.100 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Gene Arey is dated Sep 23, 2022.